Pinned Tweet
A huge thank you to all who participated in making #acspcp2026 a success! That includes all of our speakers, our panelists, our planning committee, our vendors, and most importantly...our attendees! Hope to see you back next year for #acspcp2027 @Mdcotcom @AmCollSurgeons
Exciting debate on SMR=spinal motion restriction. Can we throw out field use of the board and collar? Is it dogma vs evidence? Very exciting debate happening now in Day 2 of #acspcp2026 Presented by Dr. Tim Chizmar and Dr. Michael Millen @NAEMSP @Mdcotcom @ATSTrauma – at Baltimore, MD
Point/Counterpoint retweeted
Is MAP push beneficial in trauma patients with spinal cord injury?
I always love that debaters on both sides cite the same paper.
See the @EAST_TRAUMA multicenter study published in @TSACO_AAST #acspcp2026
tsaco.bmj.com/content/10/3/e…
Debate 2 - Nerve blocks for acute fractures in the ED?? What do you do? Dr. Samet from @shocktrauma and Dr. Osgood from @HopkinsOrtho debate! Is the risk for masking compartment syndrome outweighed by the benefit of an effective block? #acspcp2026 share your comments below! – at Baltimore, MD
Point/Counterpoint retweeted
And so it begins! Looking forward to a great Point Counterpoint conference, starting with @topknife and @SteinSister on whether mild TBI needs to be admitted @PCounterpoint
And so it begins!! Should all mild TBI be admitted? Debate #1 between @SteinSister versus @topknife gets heated! Are there exceptions to the BIG? Does age matter? Symptomatology? #acspcp2026
#acspcp2026 starts tomorrow!!! We are so pumped about the program. Great debates, thought-provoking panels, and cutting-edge keynote talks. Stay tuned for exciting content! A huge thank you to the planning committee and @cleidy30543424 for putting on this amazing event
Last minute registration -> go to mdcot.com
@pferrada1 @elliotthaut @smhenry59 @zakkarciaga @SAnandalwar @Trauma_Q @SurgEdMD @Drmribeirojr @saranimd @carrievaldezmd
Countdown to P/CP 2027: 8 days to go! Check out this video from Dr. Jen Knight-Davis from @OhioStateSurg who will be debating Dr. Dave Efron on "The Robot is Essential for ACS". Guess which side she's on? Register here: mdcot.com
We are less than 10 days away from P/CP 2026! Secure your spot now by registering at mdcot.com
And check out this testimonial from Dr. Ferrada - this year's conference will be the best one yet! #acspcp2026 @pferrada1 @smhenry59 @elliotthaut @Mdcotcom @shocktrauma
Get ready for PCP XLIII - May 7-8, 2026!!! Amazing debates, inspiring keynotes, and awesome company! Register now at mdcot.com
@EAST_TRAUMA @traumadoctorsam @Mdcotcom @traumadoctors @AmCollSurgeons
It’s that time of year again—ACS Maryland COT Point/Counterpoint XLIII 2026 is back! 🩺
Data: May 7–8, 2026
Location: Renaissance Baltimore Harborplace Hotel (Baltimore)
To register visit MDCOT.com and click on PCP 2026 to secure your seat!
Point Counterpoint 2025 was a hit! From expert trauma talks to hands-on vendor demos, it was two packed days of learning and connection in Baltimore. Huge thanks to everyone who joined us! 🙌 Mark your calendars—2026 is happening May 14–15! 📸 Find photos on Instagram & Facebook!
Thank you to all the trainees who participated in the critical care cases today! You guys took a lot of heat today from our panelists AND our audience and took it in stride. Great job and what a finale!!!
And that's a wrap! Thank you to everyone who came to this year's conference. We hope you learned a lot, saw friends old and new and had some good laughs. Tell us how we can do better next year and save the date for May 14 & 15 2026 in Baltimore! #acspcp2024
Point/Counterpoint retweeted
Carrie Valdez and Babak Sarani debate the use of laparoscopy in trauma...sure it makes sense for some, but does it make sense for every patient? How do you decide? Are we underusing? Overusing? @PCounterpoint @Mdcotcom #acspcp2025
Point/Counterpoint retweeted
GW Proud! Two great resident case presentations at Point Counterpoint! #acspcp2025 @PCounterpoint @GWSurgery @GWSurgChair @dcarreramd @mateckimary


































